Abstract

BackgroundTelaprevir is a new drug for the treatment of chronic hepatitis C virus (HCV).PurposeTo compare the safety of telaprevir treatment between HCV mono-infected patients and HIV co-infected patients.Materials and methodsRetrospective...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call